Clinical Trial Update: Erythropoietin to Improve Critical Care Patient Outcomes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating erythropoietin to improve outcomes in critical care patients with anemia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Critical Care Intensive Care

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University Hospital, Angers | Conditions: Anemia, Intensive Care | Phase 3 | Status: UNKNOWN